{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T09:32:52Z","timestamp":1769506372501,"version":"3.49.0"},"reference-count":134,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T00:00:00Z","timestamp":1753747200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T00:00:00Z","timestamp":1753747200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The COVID-19 pandemic led to disruptions in substance use and harm reduction services for people experiencing homelessness (PEH) as well as opportunities to innovate. Pandemic-era innovations may offer insights on more effective approaches to the intertwined issues of homelessness and substance use beyond the pandemic. We present findings from a scoping literature review of articles describing interventions related to substance use and homelessness that emerged during the pandemic.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We conducted a scoping literature review to identify articles on pandemic-era innovations related to substance use and homelessness. We completed a comprehensive search for articles in nine academic and grey literature databases in November 2022, and a second database search in September 2023. We screened titles, abstracts, and full text using predefined inclusion and exclusion criteria. We extracted data on study design, location, participants, and outcomes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Database searches yielded 812 unique articles; 68 met inclusion criteria. Most articles discussed interventions addressing opioid use (n\u2009=\u200960). Commonly described interventions included telemedicine-based prescribing of medications for opioid use disorder (MOUD), homeless services site-based MOUD provision, managed alcohol programs, supervised consumption services, and safer supply prescribing. Articles reported few intervention-related adverse effects, though study designs (e.g., non-experimental, observational studies lacking comparison groups) presented limitations to effectiveness outcome assessment. Surmountable challenges associated with interventions included inequitable access to technology for PEH.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Innovations in programs that provide substance use treatment and harm reduction services to PEH were observed during the COVID-19 pandemic. Further evidence is needed to determine which COVID-19 pandemic-related innovations were most impactful and how they should be prioritized and continued post-pandemic.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12954-025-01235-7","type":"journal-article","created":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T11:10:37Z","timestamp":1753787437000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Innovations at the intersection of homelessness and substance use during the COVID-19 pandemic: a scoping review"],"prefix":"10.1186","volume":"22","author":[{"given":"Hannah","family":"Passmore","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sam","family":"Craft","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Krieger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunny","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sofia","family":"Sacerdote","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Lumbis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Blaufarb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly M.","family":"Doran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,29]]},"reference":[{"key":"1235_CR1","unstructured":"Homelessness Data & Trends 2022. United States Interagency Council on Homelessness. 2022. https:\/\/www.usich.gov\/guidance-reports-data\/data-trends. Accessed 1 Apr 2024."},{"key":"1235_CR2","unstructured":"Gaetz SD, Dej E, Richter T, Redman M. The State of Homelessness in Canada 2016. Canadian Observatory on Homelessness. 2016. https:\/\/homelesshub.ca\/sites\/default\/files\/SOHC16_final_20Oct2016.pdf. Accessed 1 Apr 2024."},{"key":"1235_CR3","unstructured":"People experiencing homelessness, England and Wales: Census 2021. Office for National Statistics. 2023. https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/housing\/articles\/peopleexperiencinghomelessnessenglandandwales\/census2021. Accessed 1 Apr 2024."},{"key":"1235_CR4","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.socscimed.2015.05.005","volume":"136","author":"D McVicar","year":"2015","unstructured":"McVicar D, Moschion J, Van Ours JC. From substance use to homelessness or vice versa? Soc Sci Med. 2015;136:89\u201398.","journal-title":"Soc Sci Med"},{"issue":"4","key":"1235_CR5","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1080\/03124070802428191","volume":"61","author":"G Johnson","year":"2008","unstructured":"Johnson G, Chamberlain C. Homelessness and substance abuse: which comes first? Aust Soc Work. 2008;61(4):342\u201356.","journal-title":"Aust Soc Work"},{"issue":"9","key":"1235_CR6","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1111\/acem.13677","volume":"26","author":"KM Doran","year":"2019","unstructured":"Doran KM, Ran Z, Castelblanco D, Shelley D, Padgett DK. \u201cIt wasn\u2019t just one thing\u201d: a qualitative study of newly homeless emergency department patients. Acad Emerg Med. 2019;26(9):982\u201393.","journal-title":"Acad Emerg Med"},{"issue":"4","key":"1235_CR7","doi-asserted-by":"publisher","first-page":"S203","DOI":"10.1016\/j.whi.2011.04.005","volume":"21","author":"AB Hamilton","year":"2011","unstructured":"Hamilton AB, Poza I, Washington DL. \u201cHomelessness and trauma go hand-in-hand\u201d: pathways to homelessness among women veterans. Womens Health Issues. 2011;21(4):S203\u20139.","journal-title":"Womens Health Issues"},{"key":"1235_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12939-017-0646-3","volume":"16","author":"MA Mabhala","year":"2017","unstructured":"Mabhala MA, Yohannes A, Griffith M. Social conditions of becoming homelessness: qualitative analysis of life stories of homeless peoples. Int J Equity Health. 2017;16:1\u20136.","journal-title":"Int J Equity Health"},{"issue":"1","key":"1235_CR9","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.drugalcdep.2010.09.003","volume":"114","author":"\u00c9 Roy","year":"2011","unstructured":"Roy \u00c9, Boivin JF, Leclerc P. Initiation to drug injection among street youth: a gender-based analysis. Drug Alcohol Depend. 2011;114(1):49\u201354.","journal-title":"Drug Alcohol Depend"},{"issue":"5","key":"1235_CR10","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1111\/j.1365-2850.2010.01676.x","volume":"18","author":"S Williams","year":"2011","unstructured":"Williams S, Stickley T. Stories from the streets: people\u2019s experiences of homelessness. J Psychiatr Ment Health Nurs. 2011;18(5):432\u20139.","journal-title":"J Psychiatr Ment Health Nurs"},{"issue":"4","key":"1235_CR11","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1080\/1606635031000135631","volume":"11","author":"J Fountain","year":"2003","unstructured":"Fountain J, Howes S, Marsden J, Taylor C, Strang J. Drug and alcohol use and the link with homelessness: results from a survey of homeless people in London. Addict Res Theory. 2003;11(4):245\u201356.","journal-title":"Addict Res Theory"},{"issue":"5","key":"1235_CR12","doi-asserted-by":"publisher","first-page":"830","DOI":"10.2105\/AJPH.94.5.830","volume":"94","author":"TP O\u2019Toole","year":"2004","unstructured":"O\u2019Toole TP, Gibbon JL, Hanusa BH, Freyder PJ, Conde AM, Fine MJ. Self-reported changes in drug and alcohol use after becoming homeless. Am J Public Health. 2004;94(5):830\u20135.","journal-title":"Am J Public Health"},{"key":"1235_CR13","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s10461-005-9000-7","volume":"9","author":"A Aidala","year":"2005","unstructured":"Aidala A, Cross JE, Stall R, Harre D, Sumartojo E. Housing status and HIV risk behaviors: implications for prevention and policy. AIDS Behav. 2005;9:251\u201365.","journal-title":"AIDS Behav"},{"issue":"5","key":"1235_CR14","first-page":"436","volume":"16","author":"D Briggs","year":"2009","unstructured":"Briggs D, Rhodes T, Marks D, Kimber J, Holloway G, Jones S. Injecting drug use and unstable housing: scope for structural interventions in harm reduction. Drugs. 2009;16(5):436\u201350.","journal-title":"Drugs"},{"issue":"3","key":"1235_CR15","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.drugalcdep.2013.03.009","volume":"132","author":"SL Linton","year":"2013","unstructured":"Linton SL, Celentano DD, Kirk GD, Mehta SH. The longitudinal association between homelessness, injection drug use, and injection-related risk behavior among persons with a history of injection drug use in Baltimore, MD. Drug Alcohol Depend. 2013;132(3):457\u201365.","journal-title":"Drug Alcohol Depend"},{"key":"1235_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1472-6963-12-222","volume":"12","author":"R Canavan","year":"2012","unstructured":"Canavan R, Barry MM, Matanov A, Barros H, Gabor E, Greacen T, Holcnerov\u00e1 P, Kluge U, Nicaise P, Moskalewicz J, D\u00edaz-Olalla JM. Service provision and barriers to care for homeless people with mental health problems across 14 European capital cities. BMC Health Serv Res. 2012;12:1\u20139.","journal-title":"BMC Health Serv Res"},{"key":"1235_CR17","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.drugalcdep.2018.04.012","volume":"188","author":"A Chatterjee","year":"2018","unstructured":"Chatterjee A, Yu EJ, Tishberg L. Exploring opioid use disorder, its impact, and treatment among individuals experiencing homelessness as part of a family. Drug Alcohol Depend. 2018;188:161\u20138.","journal-title":"Drug Alcohol Depend"},{"key":"1235_CR18","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1007\/s00127-012-0649-8","volume":"48","author":"RM Krausz","year":"2013","unstructured":"Krausz RM, Clarkson AF, Strehlau V, Torchalla I, Li K, Schuetz CG. Mental disorder, service use, and barriers to care among 500 homeless people in 3 different urban settings. Soc Psychiatry Psychiatr Epidemiol. 2013;48:1235\u201343.","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"issue":"3","key":"1235_CR19","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1353\/hpu.2015.0077","volume":"26","author":"TP O\u2019Toole","year":"2015","unstructured":"O\u2019Toole TP, Johnson EE, Redihan S, Borgia M, Rose J. Needing primary care but not getting it: the role of trust, stigma and organizational obstacles reported by homeless veterans. J Health Care Poor Underserved. 2015;26(3):1019\u201331.","journal-title":"J Health Care Poor Underserved"},{"issue":"11","key":"1235_CR20","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1097\/00005650-200111000-00003","volume":"39","author":"SL Wenzel","year":"2001","unstructured":"Wenzel SL, Burnam MA, Koegel P, Morton SC, Miu A, Jinnett KJ, Sullivan JG. Access to inpatient or residential substance abuse treatment among homeless adults with alcohol or other drug use disorders. Med Care. 2001;39(11):1158\u201369.","journal-title":"Med Care"},{"key":"1235_CR21","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.1870","author":"C Cawley","year":"2022","unstructured":"Cawley C, Kanzaria HK, Zevin B, Doran KM, Kushel M, Raven MC. Mortality among people experiencing homelessness in San Francisco during the COVID-19 pandemic. JAMA Netw Open. 2022. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.1870.","journal-title":"JAMA Netw Open"},{"key":"1235_CR22","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.42676","author":"DR Fine","year":"2022","unstructured":"Fine DR, Dickins KA, Adams LD, De Las ND, Weinstock K, Wright J, et al. Drug overdose mortality among people experiencing homelessness, 2003 to 2018. JAMA Netw Open. 2022. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.42676.","journal-title":"JAMA Netw Open"},{"issue":"2","key":"1235_CR23","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1377\/hlthaff.2023.01039","volume":"43","author":"MZ Fowle","year":"2024","unstructured":"Fowle MZ, Routhier G. Mortal systemic exclusion yielded steep mortality-rate increases in people experiencing homelessness, 2011\u201320: study examines mortality among people experiencing homelessness, 2011\u201320. Health Aff. 2024;43(2):226\u201333.","journal-title":"Health Aff"},{"issue":"4","key":"1235_CR24","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1080\/17571472.2018.1458443","volume":"10","author":"K Hassanally","year":"2018","unstructured":"Hassanally K, Asaria M. Homeless mortality data from East London. London J Primary Care. 2018;10(4):99\u2013102.","journal-title":"London J Primary Care"},{"issue":"4","key":"1235_CR25","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1177\/10398562231176734","volume":"31","author":"L Woodman","year":"2023","unstructured":"Woodman L, Staples L, Karin E, Solterbeck K, Burns N, Mitchell R, Nielssen O. Rates and causes of mortality among the homeless in Sydney. Australas Psychiatry. 2023;31(4):469\u201374.","journal-title":"Australas Psychiatry"},{"issue":"3","key":"1235_CR26","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1080\/15524256.2012.708111","volume":"8","author":"SA Page","year":"2012","unstructured":"Page SA, Thurston WE, Mahoney CE. Causes of death among an urban homeless population considered by the medical examiner. J Soc Work End Life Palliat Care. 2012;8(3):265\u201371.","journal-title":"J Soc Work End Life Palliat Care"},{"issue":"2","key":"1235_CR27","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1093\/eurpub\/cky002","volume":"28","author":"MT Slockers","year":"2018","unstructured":"Slockers MT, Nusselder WJ, Rietjens J, Van Beeck EF. Unnatural death: a major but largely preventable cause-of-death among homeless people? The European Journal of Public Health. 2018;28(2):248\u201352.","journal-title":"The European Journal of Public Health"},{"key":"1235_CR28","unstructured":"Increase in fatal drug overdoses across the United States driven by synthetic opioids before and during the COVID-19 pandemic. Centers for Disease Control and Prevention. 2020. https:\/\/stacks.cdc.gov\/view\/cdc\/98848. Accessed 9 Apr 2025."},{"key":"1235_CR29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13011-019-0249-7","volume":"15","author":"S Imtiaz","year":"2020","unstructured":"Imtiaz S, Shield KD, Fischer B, Elton-Marshall T, Sornpaisarn B, Probst C, Rehm J. Recent changes in trends of opioid overdose deaths in North America. Subst Abuse Treat Prevent Policy. 2020;15:1\u20139.","journal-title":"Subst Abuse Treat Prevent Policy"},{"issue":"6","key":"1235_CR30","doi-asserted-by":"publisher","first-page":"3459","DOI":"10.3390\/ijerph19063459","volume":"19","author":"EA Adams","year":"2022","unstructured":"Adams EA, Parker J, Jablonski T, Kennedy J, Tasker F, Hunter D, Denham K, Smiles C, Muir C, O\u2019Donnell A, Widnall E. A qualitative study exploring access to mental health and substance use support among individuals experiencing homelessness during COVID-19. Int J Environ Res Public Health. 2022;19(6):3459.","journal-title":"Int J Environ Res Public Health"},{"key":"1235_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.josat.2023.209216","author":"M Hsu","year":"2024","unstructured":"Hsu M, Jung OS, Kwan LT, Jegede O, Martin B, Malhotra A, Suzuki J. Access challenges to opioid use disorder treatment among individuals experiencing homelessness: voices from the streets. J Subst Use Addict Treat. 2024. https:\/\/doi.org\/10.1016\/j.josat.2023.209216.","journal-title":"J Subst Use Addict Treat"},{"key":"1235_CR32","doi-asserted-by":"publisher","DOI":"10.1177\/23333936221108712","author":"AM Nyamathi","year":"2022","unstructured":"Nyamathi AM, Gelberg L, Lee D, Arce N, Patten-Jones A, Yadav K, Goodwine M, Alikhani M, Yao M, Chang AH, Salem BE. Perceptions of homeless adults and their providers on coping with the impact of COVID-19 pandemic on mental health, substance use, and harm reduction services. Glob Qualitat Nursing Res. 2022. https:\/\/doi.org\/10.1177\/23333936221108712.","journal-title":"Glob Qualitat Nursing Res"},{"issue":"6","key":"1235_CR33","doi-asserted-by":"publisher","first-page":"331","DOI":"10.2217\/fvl-2020-0156","volume":"15","author":"B Conway","year":"2020","unstructured":"Conway B, Truong D, Wuerth K. COVID-19 in homeless populations: unique challenges and opportunities. Futur Virol. 2020;15(6):331\u20134.","journal-title":"Futur Virol"},{"key":"1235_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2020.108177","author":"SM Murphy","year":"2021","unstructured":"Murphy SM, Yoder J, Pathak J, Avery J. Healthcare utilization patterns among persons who use drugs during the COVID-19 pandemic. J Subst Abuse Treat. 2021. https:\/\/doi.org\/10.1016\/j.jsat.2020.108177.","journal-title":"J Subst Abuse Treat"},{"issue":"26","key":"1235_CR35","doi-asserted-by":"publisher","first-page":"E716","DOI":"10.1503\/cmaj.200834","volume":"192","author":"M Perri","year":"2020","unstructured":"Perri M, Dosani N, Hwang SW. COVID-19 and people experiencing homelessness: challenges and mitigation strategies. CMAJ. 2020;192(26):E716\u20139.","journal-title":"CMAJ"},{"key":"1235_CR36","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.10452","author":"A Appa","year":"2021","unstructured":"Appa A, Rodda LN, Cawley C, Zevin B, Coffin PO, Gandhi M, Imbert E. Drug overdose deaths before and after shelter-in-place orders during the COVID-19 pandemic in San Francisco. JAMA Netw Open. 2021. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.10452.","journal-title":"JAMA Netw Open"},{"issue":"6","key":"1235_CR37","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1111\/add.15823","volume":"117","author":"M Liu","year":"2022","unstructured":"Liu M, Richard L, Campitelli MA, Nisenbaum R, Dosani N, Dhalla IA, et al. Drug overdoses during the COVID-19 pandemic among recently homeless individuals. Addiction. 2022;117(6):1692\u2013701.","journal-title":"Addiction"},{"issue":"3","key":"1235_CR38","first-page":"E685","volume":"10","author":"K Hodwitz","year":"2022","unstructured":"Hodwitz K, Parsons J, Juando-Prats C, Rosenthal E, Craig-Neil A, Hwang SW, et al. Challenges faced by people experiencing homelessness and their providers during the COVID-19 pandemic: a qualitative study. Can Med Assoc Open Access J. 2022;10(3):E685\u201391.","journal-title":"Can Med Assoc Open Access J"},{"issue":"6","key":"1235_CR39","doi-asserted-by":"publisher","first-page":"e6553","DOI":"10.1111\/hsc.14103","volume":"30","author":"LK McCosker","year":"2022","unstructured":"McCosker LK, Ware RS, Maujean A, Seale H, Downes MJ. Impacts of the COVID-19 pandemic, and of government responses to the pandemic, on people who are homeless in Australia: Mapping perceptions of a national sample of homelessness service workers. Health Soc Care Community. 2022;30(6):e6553\u201363.","journal-title":"Health Soc Care Community"},{"key":"1235_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-020-00370-7","author":"A Dunlop","year":"2020","unstructured":"Dunlop A, Lokuge B, Masters D, Sequeira M, Saul P, Dunlop G, et al. Challenges in maintaining treatment services for people who use drugs during the COVID-19 pandemic. Harm Reduction J. 2020. https:\/\/doi.org\/10.1186\/s12954-020-00370-7.","journal-title":"Harm Reduction J"},{"issue":"4","key":"1235_CR41","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.jadohealth.2020.07.013","volume":"67","author":"JS Tucker","year":"2020","unstructured":"Tucker JS, D\u2019Amico EJ, Pedersen ER, Garvey R, Rodriguez A, Klein DJ. Behavioral health and service usage during the COVID-19 pandemic among emerging adults currently or recently experiencing homelessness. J Adolesc Health. 2020;67(4):603\u20135.","journal-title":"J Adolesc Health"},{"key":"1235_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph182212094","author":"D de Vargas","year":"2021","unstructured":"de Vargas D, Pereira CF, Volpato RJ, Lima AV, da Silva FR, de Oliveira SR, Aguilar TF. Strategies adopted by addiction facilities during the coronavirus pandemic to support treatment for individuals in recovery or struggling with a substance use disorder: a scoping review. Int J Environ Res Public Health. 2021. https:\/\/doi.org\/10.3390\/ijerph182212094.","journal-title":"Int J Environ Res Public Health"},{"key":"1235_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13722-021-00275-1","volume":"16","author":"N Krawczyk","year":"2021","unstructured":"Krawczyk N, Fawole A, Yang J, Tofighi B. Early innovations in opioid use disorder treatment and harm reduction during the COVID-19 pandemic: a scoping review. Addict Sci Clin Pract. 2021;16:1\u20135.","journal-title":"Addict Sci Clin Pract"},{"issue":"3\/4","key":"1235_CR44","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1108\/HCS-11-2020-0018","volume":"24","author":"A Oudshoorn","year":"2021","unstructured":"Oudshoorn A, Benjamin T, Smith-Carrier TA, Benbow S, Marshall CA, Kennedy R, Hall J, Caxaj CS, Berman H, Befus D. A rapid review of practices to support people experiencing homelessness during COVID-19. Housing Care Support. 2021;24(3\/4):105\u201322.","journal-title":"Housing Care Support"},{"key":"1235_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1748-5908-5-69","volume":"5","author":"D Levac","year":"2010","unstructured":"Levac D, Colquhoun H, O\u2019Brien KK. Scoping studies: advancing the methodology. Implement Sci. 2010;5:1\u20139.","journal-title":"Implement Sci"},{"key":"1235_CR46","unstructured":"Covidence systematic review software. Veritas Health Innovation, Melbourne, 2022."},{"key":"1235_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2288-9-59","volume":"9","author":"E Barnett-Page","year":"2009","unstructured":"Barnett-Page E, Thomas J. Methods for the synthesis of qualitative research: a critical review. BMC Med Res Methodol. 2009;9:1\u20131.","journal-title":"BMC Med Res Methodol"},{"key":"1235_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12874-016-0116-4","volume":"16","author":"AC Tricco","year":"2016","unstructured":"Tricco AC, Lillie E, Zarin W, O\u2019brien K, Colquhoun H, Kastner M, et al. A scoping review on the conduct and reporting of scoping reviews. BMC Med Res Methodol. 2016;16:1\u201310.","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"1235_CR49","doi-asserted-by":"publisher","first-page":"32","DOI":"10.12968\/jprp.2022.4.1.32","volume":"4","author":"J Dunn","year":"2022","unstructured":"Dunn J, McCallion R, Simonson H. Setting up a drug treatment service in a COVID-protect hotel in inner London. J Prescrib Pract. 2022;4(1):32\u201340.","journal-title":"J Prescrib Pract"},{"key":"1235_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-021-00463-x","author":"R Fuertes","year":"2021","unstructured":"Fuertes R, Belo E, Merendeiro C, Curado A, Gautier D, Neto A, Taylor H. Lisbon\u2019s COVID 19 response: harm reduction interventions for people who use alcohol and other drugs in emergency shelters. Harm Reduct J. 2021. https:\/\/doi.org\/10.1186\/s12954-021-00463-x.","journal-title":"Harm Reduct J"},{"issue":"5","key":"1235_CR51","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1177\/00333549211032974","volume":"136","author":"MTH Harris","year":"2021","unstructured":"Harris MTH, Young S, Barocas J, Bayoumi AM, Caudarella A, Laurence G, et al. A descriptive comparison of substance use services in recovery and isolation sites for people experiencing homelessness during the COVID-19 pandemic. Boston and Toronto Public Health Rep. 2021;136(5):532\u20137.","journal-title":"Boston and Toronto Public Health Rep"},{"key":"1235_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/s13722-021-00221-1","author":"MTH Harris","year":"2021","unstructured":"Harris MTH, Peterkin A, Bach P, Englander H, Lapidus E, Rolley T, et al. Adapting inpatient addiction medicine consult services during the COVID-19 pandemic. Addict Sci Clin Pract. 2021. https:\/\/doi.org\/10.1186\/s13722-021-00221-1.","journal-title":"Addict Sci Clin Pract"},{"issue":"4","key":"1235_CR53","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1007\/s11524-020-00465-3","volume":"97","author":"R Heimer","year":"2020","unstructured":"Heimer R, McNeil R, Vlahov D. A community responds to the COVID-19 pandemic: a case study in protecting the health and human rights of people who use drugs. J Urban Health. 2020;97(4):448\u201356.","journal-title":"J Urban Health"},{"key":"1235_CR54","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1097\/ADM.0000000000001034","volume":"17","author":"AJ Kennedy","year":"2022","unstructured":"Kennedy AJ, George JS, Rossetti G, Brown CO, Ragins K, Dadiomov D, et al. Providing low-barrier addiction treatment via a telemedicine consultation service during the COVID-19 pandemic in los angeles, county: an assessment 1 year later. J Addict Med. 2022;17:64\u20136.","journal-title":"J Addict Med"},{"key":"1235_CR55","first-page":"448","volume":"36","author":"M Komaromy","year":"2020","unstructured":"Komaromy M, Harris M, Koenig RM, Tomanovich M, Ruiz-Mercado G, Barocas JA. Caring for COVID\u2019s most vulnerable victims: a safety-net hospital responds. Res Sq. 2020;36:448\u201351.","journal-title":"Res Sq"},{"issue":"6","key":"1235_CR56","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1097\/ADM.0000000000000791","volume":"15","author":"M Komaromy","year":"2021","unstructured":"Komaromy M, Tomanovich M, Taylor JL, Ruiz-Mercado G, Kimmel SD, Bagley SM, et al. Adaptation of a system of treatment for substance use disorders during the COVID-19 pandemic. J Addict Med. 2021;15(6):448\u201351.","journal-title":"J Addict Med"},{"issue":"2","key":"1235_CR57","doi-asserted-by":"publisher","first-page":"96","DOI":"10.32481\/djph.2020.07.023","volume":"6","author":"R Landgraf","year":"2020","unstructured":"Landgraf R, Holloway S, Beaman R, Fitzgerald R. Delaware COVID-19 homeless community outreach partnership 2020. Dela J Public Health. 2020;6(2):96\u2013100.","journal-title":"Dela J Public Health"},{"key":"1235_CR58","doi-asserted-by":"publisher","DOI":"10.1370\/afm.2636","author":"P Leo","year":"2021","unstructured":"Leo P, Gastala N, Fleurimont J, Messmer S, Maes P, Richardson J, et al. A community partnership to improve access to buprenorphine in a homeless population. Ann Fam Med. 2021. https:\/\/doi.org\/10.1370\/afm.2636.","journal-title":"Ann Fam Med"},{"key":"1235_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/21501319231180448","volume":"14","author":"KA Lynch","year":"2023","unstructured":"Lynch KA, McCoy M, Gabrielian S. Veterans finding community and a \u201chome\u201d within an emergency housing environment. J Primary Care Community Health. 2023;14:1\u20134.","journal-title":"J Primary Care Community Health"},{"key":"1235_CR60","doi-asserted-by":"publisher","DOI":"10.1186\/s12939-022-01628-1","author":"D Malmusi","year":"2022","unstructured":"Malmusi D, Pasar\u00edn MI, Mar\u00ed-Dell\u2019Olmo M, Artazcoz L, Diez E, Tolosa S, et al. Multi-level policy responses to tackle socioeconomic inequalities in the incidence of COVID-19 in a European urban area. Int J Equity Health. 2022. https:\/\/doi.org\/10.1186\/s12939-022-01628-1.","journal-title":"Int J Equity Health"},{"key":"1235_CR61","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-020-00404-0","author":"TS Marcus","year":"2020","unstructured":"Marcus TS, Heese J, Scheibe A, Shelly S, Lalla SX, Hugo JF. Harm reduction in an emergency response to homelessness during South Africa\u2019s COVID-19 lockdown. Harm Reduct J. 2020. https:\/\/doi.org\/10.1186\/s12954-020-00404-0.","journal-title":"Harm Reduct J"},{"key":"1235_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.josat.2023.209054","author":"SE Messmer","year":"2023","unstructured":"Messmer SE, Elmes AT, Jimenez AD, Murphy AL, Guzman M, Watson DP, et al. Outcomes of a mobile medical unit for low-threshold buprenorphine access targeting opioid overdose hot spots in Chicago. J Subst Use Addict Treat. 2023. https:\/\/doi.org\/10.1016\/j.josat.2023.209054.","journal-title":"J Subst Use Addict Treat"},{"key":"1235_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2020.102966","author":"A O\u2019Carroll","year":"2021","unstructured":"O\u2019Carroll A, Duffin T, Collins J. Harm reduction in the time of COVID-19: case study of homelessness and drug use in Dublin, Ireland. Int J Drug Policy. 2021. https:\/\/doi.org\/10.1016\/j.drugpo.2020.102966.","journal-title":"Int J Drug Policy"},{"key":"1235_CR64","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1111\/dar.13506","volume":"41","author":"E Nash","year":"2022","unstructured":"Nash E, Walker E, Watt J, Sannikova A, Dawson A, Anderson T, et al. Management of alcohol and other drug issues in Special Health Accommodation during the COVID-19 delta variant outbreak in Sydney, 2021. Drug Alcohol Rev. 2022;41:1319\u201321.","journal-title":"Drug Alcohol Rev"},{"issue":"4","key":"1235_CR65","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1097\/ADM.0000000000000764","volume":"15","author":"DS Qui\u00f1ones","year":"2021","unstructured":"Qui\u00f1ones DS, Melin K, Roman L, Rodriguez F, Alvarado J, Rodr\u00edguez-D\u00edaz CE. Treating opioid use disorder in puerto rico during the COVID-19 pandemic: providers\u2019 leadership efforts in unprecedented times. J Addict Med. 2021;15(4):276\u20139.","journal-title":"J Addict Med"},{"issue":"2","key":"1235_CR66","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1080\/08897077.2021.1892012","volume":"42","author":"J Ristau","year":"2021","unstructured":"Ristau J, Mehtani N, Gomez S, Nance M, Keller D, Surlyn C, et al. Successful implementation of managed alcohol programs in the San Francisco Bay Area during the COVID-19 crisis. Subst Abus. 2021;42(2):140\u20137.","journal-title":"Subst Abus"},{"issue":"3","key":"1235_CR67","first-page":"196","volume":"118","author":"F Rottnek","year":"2021","unstructured":"Rottnek F, Laxton A. Homeless and COVID-19: interventions for an acute exacerbation of a chronic condition. Mo Med. 2021;118(3):196\u2013202.","journal-title":"Mo Med"},{"key":"1235_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2021.103570","author":"A Sivakumar","year":"2022","unstructured":"Sivakumar A, Madden L, DiDomizio E, Eller A, Villanueva M, Altice FL. Treatment of Hepatitis C virus among people who inject drugs at a syringe service program during the COVID-19 response: the potential role of telehealth, medications for opioid use disorder and minimal demands on patients. Int J Drug Policy. 2022. https:\/\/doi.org\/10.1016\/j.drugpo.2021.103570.","journal-title":"Int J Drug Policy"},{"issue":"1","key":"1235_CR69","doi-asserted-by":"publisher","first-page":"E40","DOI":"10.1097\/ADM.0000000000000809","volume":"16","author":"B Tofighi","year":"2022","unstructured":"Tofighi B, McNeely J, Walzer D, Fansiwala K, Demner A, Chaudhury CS, et al. A telemedicine buprenorphine clinic to serve New York city: initial evaluation of the NYC public hospital system\u2019s initiative to expand treatment access during the COVID-19 pandemic. J Addict Med. 2022;16(1):E40\u20133.","journal-title":"J Addict Med"},{"key":"1235_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2020.108181","author":"R Tringale","year":"2021","unstructured":"Tringale R, Subica AM. COVID-19 innovations in medication for addiction treatment at a Skid Row syringe exchange. J Subst Abuse Treat. 2021. https:\/\/doi.org\/10.1016\/j.jsat.2020.108181.","journal-title":"J Subst Abuse Treat"},{"issue":"3\u20134","key":"1235_CR71","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1080\/21528586.2021.2015624","volume":"51","author":"O Venter","year":"2020","unstructured":"Venter O, Heese J. Homelessness and community based healthcare: a narrative experience in a temporary shelter amidst the COVID-19 pandemic. South African Review of Sociology. 2020;51(3\u20134):28\u201339.","journal-title":"South African Review of Sociology"},{"issue":"7","key":"1235_CR72","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.2105\/AJPH.2021.306286","volume":"111","author":"CY Wang","year":"2021","unstructured":"Wang CY, Palma ML, Haley C, Watts J, Hinami K. Rapid creation of a multiagency alternate care site for COVID-19\u2013positive individuals experiencing homelessness. Am J Public Health. 2021;111(7):1227\u201330.","journal-title":"Am J Public Health"},{"key":"1235_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2020.108272","author":"L Wang","year":"2021","unstructured":"Wang L, Weiss J, Ryan EB, Waldman J, Rubin S, Griffin JL. Telemedicine increases access to buprenorphine initiation during the COVID-19 pandemic. J Subst Abuse Treat. 2021. https:\/\/doi.org\/10.1016\/j.jsat.2020.108272.","journal-title":"J Subst Abuse Treat"},{"key":"1235_CR74","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-021-00578-1","author":"EJ Yeo","year":"2021","unstructured":"Yeo EJ, Kralles H, Sternberg D, McCullough D, Nadanasabesan A, Mayo R, et al. Implementing a low-threshold audio-only telehealth model for medication-assisted treatment of opioid use disorder at a community-based non-profit organization in Washington, D.C. Harm Reduct J. 2021. https:\/\/doi.org\/10.1186\/s12954-021-00578-1.","journal-title":"Harm Reduct J"},{"key":"1235_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.ssmqr.2021.100013","author":"SV Aronowitz","year":"2021","unstructured":"Aronowitz SV, Engel-Rebitzer E, Lowenstein M, Meisel Z, Anderson E, South E. \u201cWe have to be uncomfortable and creative\u201d: reflections on the impacts of the COVID-19 pandemic on overdose prevention, harm reduction & homelessness advocacy in Philadelphia. SSM Qual Res Health. 2021. https:\/\/doi.org\/10.1016\/j.ssmqr.2021.100013.","journal-title":"SSM Qual Res Health"},{"key":"1235_CR76","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-021-00574-5","author":"H Brocious","year":"2021","unstructured":"Brocious H, Trawver K, Demientieff LX. Managed alcohol: one community\u2019s innovative response to risk management during COVID-19. Harm Reduct J. 2021. https:\/\/doi.org\/10.1186\/s12954-021-00574-5.","journal-title":"Harm Reduct J"},{"key":"1235_CR77","doi-asserted-by":"publisher","DOI":"10.1186\/s13722-023-00372-3","author":"JB Darnton","year":"2023","unstructured":"Darnton JB, Bhatraju EP, Beima-Sofie K, Michaels A, Hallgren KA, Soth S, et al. \u201cSign Me Up\u201d: a qualitative study of video observed therapy (VOT) for patients receiving expedited methadone take-homes during the COVID-19 pandemic. Addict Sci Clin Pract. 2023. https:\/\/doi.org\/10.1186\/s13722-023-00372-3.","journal-title":"Addict Sci Clin Pract"},{"key":"1235_CR78","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2021.108655","author":"MTH Harris","year":"2022","unstructured":"Harris MTH, Lambert AM, Maschke AD, Bagley SM, Walley AY, Gunn CM. \u201cNo home to take methadone to\u201d: experiences with addiction services during the COVID-19 pandemic among survivors of opioid overdose in Boston. J Subst Abuse Treat. 2022. https:\/\/doi.org\/10.1016\/j.jsat.2021.108655.","journal-title":"J Subst Abuse Treat"},{"key":"1235_CR79","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2021.103391","author":"JM Kesten","year":"2021","unstructured":"Kesten JM, Holland A, Linton MJ, Family H, Scott J, Horwood J, et al. Living under coronavirus and injecting drugs in bristol (LUCID-B): a qualitative study of experiences of COVID-19 among people who inject drugs. Int J Drug Policy. 2021. https:\/\/doi.org\/10.1016\/j.drugpo.2021.103391.","journal-title":"Int J Drug Policy"},{"key":"1235_CR80","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1136\/medhum-2021-012367","volume":"49","author":"J Lenhard","year":"2022","unstructured":"Lenhard J, Margetts M, Meng E. Of not passing: homelessness, addiction, mental health and care during COVID-19. Med Humanit. 2022;49:55\u201363.","journal-title":"Med Humanit"},{"issue":"1","key":"1235_CR81","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1080\/08897077.2022.2060447","volume":"43","author":"R Lockard","year":"2022","unstructured":"Lockard R, Priest KC, Gregg J, Buchheit BM. A qualitative study of patient experiences with telemedicine opioid use disorder treatment during COVID-19. Subst Abus. 2022;43(1):1150\u20137.","journal-title":"Subst Abus"},{"key":"1235_CR82","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2022.103752","author":"T May","year":"2022","unstructured":"May T, Dawes J, Fancourt D, Burton A. A qualitative study exploring the impact of the COVID-19 pandemic on People Who Inject Drugs (PWID) and drug service provision in the UK: PWID and service provider perspectives. Int J Drug Policy. 2022. https:\/\/doi.org\/10.1016\/j.drugpo.2022.103752.","journal-title":"Int J Drug Policy"},{"key":"1235_CR83","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-022-12976-6","author":"V McCann","year":"2022","unstructured":"McCann V, Allen R, Purkey E. Exploring the impact of COVID-19 on substance use patterns and service access of street involved individuals in Kingston, Ontario: a qualitative study. BMC Public Health. 2022. https:\/\/doi.org\/10.1186\/s12889-022-12976-6.","journal-title":"BMC Public Health"},{"key":"1235_CR84","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2022.103818","author":"J Neale","year":"2022","unstructured":"Neale J, Parkin S, Hermann L, Metrebian N, Roberts E, Robson D, Strang J. Substance use and homelessness: a longitudinal interview study conducted during COVID-19 with implications for policy and practice. Int J Drug Policy. 2022. https:\/\/doi.org\/10.1016\/j.drugpo.2022.103818.","journal-title":"Int J Drug Policy"},{"key":"1235_CR85","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-021-00508-1","author":"T Parkes","year":"2021","unstructured":"Parkes T, Carver H, Masterton W, Falzon D, Dumbrell J, Grant S, Wilson I. \u201cYou know, we can change the services to suit the circumstances of what is happening in the world\u201d: a rapid case study of the COVID-19 response across city centre homelessness and health services in Edinburgh. Scotland Harm Reduct J. 2021. https:\/\/doi.org\/10.1186\/s12954-021-00508-1.","journal-title":"Scotland Harm Reduct J"},{"key":"1235_CR86","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-021-00472-w","author":"T Parkes","year":"2021","unstructured":"Parkes T, Carver H, Masterton W, Falzon D, Dumbrell J, Grant S, Wilson I. \u2018They already operated like it was a crisis, because it always has been a crisis\u2019: a qualitative exploration of the response of one homeless service in Scotland to the COVID-19 pandemic. Harm Reduct J. 2021. https:\/\/doi.org\/10.1186\/s12954-021-00472-w.","journal-title":"Harm Reduct J"},{"key":"1235_CR87","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2021.108374","author":"C Russell","year":"2021","unstructured":"Russell C, Ali F, Nafeh F, Rehm J, LeBlanc S, Elton-Marshall T. Identifying the impacts of the COVID-19 pandemic on service access for people who use drugs (PWUD): a national qualitative study. J Subst Abuse Treat. 2021. https:\/\/doi.org\/10.1016\/j.jsat.2021.108374.","journal-title":"J Subst Abuse Treat"},{"key":"1235_CR88","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-022-12873-y","author":"J Schofield","year":"2022","unstructured":"Schofield J, Dumbrell J, Matheson C, Parkes T, Bancroft A. The impact of COVID-19 on access to harm reduction, substance use treatment and recovery services in Scotland: a qualitative study. BMC Public Health. 2022. https:\/\/doi.org\/10.1186\/s12889-022-12873-y.","journal-title":"BMC Public Health"},{"issue":"1","key":"1235_CR89","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1080\/08897077.2022.2060438","volume":"43","author":"LW Suen","year":"2022","unstructured":"Suen LW, Castellanos S, Joshi N, Satterwhite S, Knight KR. \u201cThe idea is to help people achieve greater success and liberty\u201d: a qualitative study of expanded methadone take-home access in opioid use disorder treatment. Subst Abus. 2022;43(1):1143\u201350.","journal-title":"Subst Abus"},{"issue":"Suppl","key":"1235_CR90","doi-asserted-by":"publisher","first-page":"143","DOI":"10.2105\/AJPH.2022.306806","volume":"112","author":"JP Wyatt","year":"2022","unstructured":"Wyatt JP, Suen LW, Coe WH, Adams ZM, Gandhi M, Batchelor HM, et al. Federal and state regulatory changes to methadone take-home doses: impact of sociostructural factors. Am J Public Health. 2022;112(Suppl):143\u20136.","journal-title":"Am J Public Health"},{"key":"1235_CR91","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyg.2023.1165322","author":"FO Azevedo","year":"2023","unstructured":"Azevedo FO, Neto A, Gama A, Subtil A, Fuertes R, Pereira C, et al. Problemas ligados ao \u00e1lcool em centros de emerg\u00eancia (PLACE)-People experiencing homelessness with alcohol-related problems in Lisbon\u2019s emergency shelters during the COVID-19 pandemic: a description and analysis of a harm reduction intervention. Front Psychol. 2023. https:\/\/doi.org\/10.3389\/fpsyg.2023.1165322.","journal-title":"Front Psychol"},{"key":"1235_CR92","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.23891","author":"MD Fleming","year":"2022","unstructured":"Fleming MD, Evans JL, Graham-Squire D, Cawley C, Kanzaria HK, Kushel MB, Raven MC. Association of shelter-in-place hotels with health services use among people experiencing homelessness during the COVID-19 Pandemic. JAMA Netw Open. 2022. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.23891.","journal-title":"JAMA Netw Open"},{"key":"1235_CR93","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.36298","author":"MC Frost","year":"2022","unstructured":"Frost MC, Zhang L, Kim HM, Lin LA. Use of and retention on video, telephone, and in-person buprenorphine treatment for opioid use disorder during the COVID-19 pandemic. JAMA Netw Open. 2022. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.36298.","journal-title":"JAMA Netw Open"},{"key":"1235_CR94","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.0490","author":"JD Fuchs","year":"2021","unstructured":"Fuchs JD, Carter HC, Evans J, Graham-Squire D, Imbert E, Bloome J, et al. Assessment of a hotel-based COVID-19 isolation and quarantine strategy for persons experiencing homelessness. JAMA Netw Open. 2021. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.0490.","journal-title":"JAMA Netw Open"},{"key":"1235_CR95","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2023.1147558","author":"M Horig","year":"2023","unstructured":"Horig M, Klaes SM, Krasovski-Nikiforovs S, van Loon W, Murajda L, Rodriguez RCO, et al. A COVID-19 isolation facility for people experiencing homelessness in Berlin, Germany: a retrospective patient record study. Front Public Health. 2023. https:\/\/doi.org\/10.3389\/fpubh.2023.1147558.","journal-title":"Front Public Health"},{"key":"1235_CR96","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.38464","author":"TD Huggett","year":"2021","unstructured":"Huggett TD, Tung EL, Cunningham M, Ghinai I, Duncan HL, McCauley ME, Detmer WM. Assessment of a hotel-based protective housing program for incidence of SARS-CoV-2 infection and management of chronic illness among persons experiencing homelessness. JAMA Netw Open. 2021. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.38464.","journal-title":"JAMA Netw Open"},{"issue":"4","key":"1235_CR97","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1007\/s11414-023-09837-4","volume":"50","author":"C King","year":"2023","unstructured":"King C, Douglas D, Avalone L, Appleton N, Linn-Walton R, Barron C, McNeely J. Telephonic outreach to engage patients with substance use disorder post-hospitalization during the COVID-19 pandemic. J Behav Health Serv Res. 2023;50(4):540\u20137.","journal-title":"J Behav Health Serv Res"},{"key":"1235_CR98","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-022-00614-8","author":"B Lew","year":"2022","unstructured":"Lew B, Bodkin C, Lennox R, O\u2019Shea T, Wiwcharuk G, Turner S. The impact of an integrated safer use space and safer supply program on non-fatal overdose among emergency shelter residents during a COVID-19 outbreak: a case study. Harm Reduct J. 2022. https:\/\/doi.org\/10.1186\/s12954-022-00614-8.","journal-title":"Harm Reduct J"},{"key":"1235_CR99","first-page":"148","volume":"06","author":"EB Matthews","year":"2023","unstructured":"Matthews EB, Lushin V, Rzewinski J. Patterns & predictors of telehealth utilization among individuals who use substances: implications for the future of virtual behavioral health services. Community Ment Health J. 2023;06:148\u201353.","journal-title":"Community Ment Health J"},{"issue":"5","key":"1235_CR100","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1097\/ADM.0000000000000774","volume":"15","author":"CDBA Nordeck","year":"2021","unstructured":"Nordeck CDBA, Buresh MMD, Krawczyk NP, Fingerhood MMD, Agus DJD. Adapting a low-threshold buprenorphine program for vulnerable populations during the COVID-19 pandemic. J Addict Med. 2021;15(5):364\u20139.","journal-title":"J Addict Med"},{"issue":"4","key":"1235_CR101","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1080\/10826084.2023.2170184","volume":"58","author":"AF Peterkin","year":"2023","unstructured":"Peterkin AF, Jawa R, Menezes K, You J, Cabral H, Ruiz-Mercado G, et al. Pre-paid phone distribution: a tool for improving healthcare engagement for people with substance use disorder. Subst Use Misuse. 2023;58(4):585\u20139.","journal-title":"Subst Use Misuse"},{"key":"1235_CR102","doi-asserted-by":"publisher","DOI":"10.4102\/safp.v65i1.5708","author":"JMA Siemens","year":"2023","unstructured":"Siemens JMA, Bhoora U, van Rensburg MJ. Methadone use for acute opioid withdrawal in Tshwane shelters during the COVID-19 lockdown. South Afr Family Pract. 2023. https:\/\/doi.org\/10.4102\/safp.v65i1.5708.","journal-title":"South Afr Family Pract"},{"key":"1235_CR103","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajp.2021.102987","author":"MU Toseef","year":"2022","unstructured":"Toseef MU, Armistead I, Bacon E, Hawkins E, Bender B, Podewils LJ, Hurley H. Missed appointments during COVID-19: the impact of telehealth for persons experiencing homelessness with substance use disorders. Asian J Psychiatr. 2022. https:\/\/doi.org\/10.1016\/j.ajp.2021.102987.","journal-title":"Asian J Psychiatr"},{"issue":"1","key":"1235_CR104","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1159\/000527826","volume":"29","author":"F Vorberg","year":"2023","unstructured":"Vorberg F, Reimer J, Verthein U. Feasibility and short-term effects of low-threshold opioid substitution treatment during the COVID-19 pandemic in hamburg. Germany Eur Addict Res. 2023;29(1):44\u201351.","journal-title":"Germany Eur Addict Res"},{"key":"1235_CR105","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2022.109440","author":"TD Brothers","year":"2022","unstructured":"Brothers TD, Leaman M, Bonn M, Lewer D, Atkinson J, Fraser J, et al. Evaluation of an emergency safe supply drugs and managed alcohol program in COVID-19 isolation hotel shelters for people experiencing homelessness. Drug Alcohol Depend. 2022. https:\/\/doi.org\/10.1016\/j.drugalcdep.2022.109440.","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"1235_CR106","doi-asserted-by":"publisher","first-page":"e59","DOI":"10.1097\/ADM.0000000000000836","volume":"16","author":"L Flavin","year":"2022","unstructured":"Flavin L, Tofighi B, Krawczyk N, Schatz D, McNeely J, Butner JL. Low threshold telemedicine-based opioid treatment for criminal justice involved adults during the COVID-19 pandemic: a case report. J Addict Med. 2022;16(1):e59\u201361.","journal-title":"J Addict Med"},{"issue":"4","key":"1235_CR107","doi-asserted-by":"publisher","first-page":"e136","DOI":"10.1097\/ADM.0000000000000682","volume":"14","author":"M Harris","year":"2020","unstructured":"Harris M, Johnson S, Mackin S, Saitz R, Walley AY, Taylor JL. Low barrier tele-buprenorphine in the time of COVID-19: a case report. J Addict Med. 2020;14(4):e136\u20138.","journal-title":"J Addict Med"},{"issue":"5","key":"1235_CR108","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1097\/ADM.0000000000000954","volume":"16","author":"RH Hong","year":"2022","unstructured":"Hong RH, Brar R, Fairbairn N. Supporting self-isolation for COVID-19 with \u201crisk mitigation\u201d prescribing and housing supports for people who use drugs: a case report. J Addict Med. 2022;16(5):592\u20134.","journal-title":"J Addict Med"},{"issue":"1","key":"1235_CR109","doi-asserted-by":"publisher","first-page":"e56","DOI":"10.1097\/ADM.0000000000000811","volume":"16","author":"XA Levander","year":"2022","unstructured":"Levander XA, Wheelock H, Pope J, Lee A, Hartmann K, Abuelkhair S, et al. Low-threshold buprenorphine via community partnerships and telemedicine-case reports of expanding access to addiction treatment during COVID-19. J Addict Med. 2022;16(1):e56\u20138.","journal-title":"J Addict Med"},{"issue":"2","key":"1235_CR110","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1080\/08897077.2021.1890676","volume":"42","author":"NJ Mehtani","year":"2021","unstructured":"Mehtani NJ, Ristau JT, Snyder H, Surlyn C, Eveland J, Smith-Bernardin S, Knight KR. COVID-19: a catalyst for change in telehealth service delivery for opioid use disorder management. Subst Abus. 2021;42(2):205\u201312.","journal-title":"Subst Abus"},{"key":"1235_CR111","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1097\/ADM.0000000000000989","volume":"16","author":"L Samuel","year":"2022","unstructured":"Samuel L, Caygill-Walsh R, Suen LW, Mohebbi S, Geier M. Triple threat: response to the crises of COVID-19, homelessness, and opioid use disorder with a novel approach to buprenorphine delivery: a case series. J Addict Med. 2022;16:733\u20135.","journal-title":"J Addict Med"},{"issue":"1","key":"1235_CR112","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/dar.13335","volume":"41","author":"E Scallan","year":"2022","unstructured":"Scallan E, Bodkin C, Wiwcharuk J, O\u2019Shea T, Lennox R. Finding stability amidst the COVID-19 pandemic: the impact of emergency temporary housing for people who use drugs. Drug Alcohol Rev. 2022;41(1):7\u20138.","journal-title":"Drug Alcohol Rev"},{"issue":"2","key":"1235_CR113","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s11524-022-00705-8","volume":"100","author":"E Abbs","year":"2023","unstructured":"Abbs E, Schoenfeld N, Lai M, Satterwhite S, Zhou S, Bamberger J, Zevin B. Care and complexity in emergency housing: an examination of the COVID-19 shelter-in-place (SIP) hotel program to house people experiencing homelessness in San Francisco. J Urban Health. 2023;100(2):303\u201313.","journal-title":"J Urban Health"},{"key":"1235_CR114","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1002\/hpja.717","volume":"34","author":"M Bower","year":"2023","unstructured":"Bower M, Olsen N, Peach N, Green O, Duarte C, Valpiani P, Teesson M. Feasibility of telehealth counselling pilot for people experiencing homelessness and\/or complex needs - during COVID-19 and beyond. Health Promot J Australia. 2023;34:889\u201394.","journal-title":"Health Promot J Australia"},{"issue":"5","key":"1235_CR115","doi-asserted-by":"publisher","first-page":"787","DOI":"10.17269\/s41997-023-00803-3","volume":"114","author":"LR Galarneau","year":"2023","unstructured":"Galarneau LR, Speed K, Taylor M, Hyshka E. Operating an overdose prevention site within a temporary emergency shelter during the COVID-19 pandemic. Can J Public Health. 2023;114(5):787\u201395.","journal-title":"Can J Public Health"},{"key":"1235_CR116","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1007\/s10461-022-03851-x","volume":"27","author":"L Wiessing","year":"2022","unstructured":"Wiessing L, Sypsa V, Abagiu AO, Arble A, Berndt N, Bosch A, et al. Impact of COVID-19 & response measures on HIV-HCV prevention services and social determinants in people who inject drugs in 13 sites with recent HIV outbreaks in Europe. North America Israel AIDS Behav. 2022;27:1140\u201353.","journal-title":"North America Israel AIDS Behav"},{"key":"1235_CR117","unstructured":"The 2024 Annual Homelessness Assessment Report (AHAR) to Congress. United States Department of Housing and Urban Development. 2024. https:\/\/www.huduser.gov\/portal\/datasets\/ahar\/2024-ahar-part-1-pit-estimates-of-homelessness-in-the-us.html. Accessed 9 Apr 2025."},{"issue":"2","key":"1235_CR118","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1111\/add.16357","volume":"119","author":"RG Booth","year":"2024","unstructured":"Booth RG, Shariff SZ, Carter B, Hwang SW, Orkin AM, Forchuk C, Gomes T. Opioid-related overdose deaths among people experiencing homelessness, 2017 to 2021: a population-based analysis using coroner and health administrative data from Ontario. Canada Addiction. 2024;119(2):334\u201344.","journal-title":"Canada Addiction"},{"key":"1235_CR119","doi-asserted-by":"publisher","unstructured":"Kochanek KD, Murphy SL, Xu JQ, Arias E. 2024. Mortality in the United States, 2022. NCHS Data Brief, no 492. National Center for Health Statistics. https:\/\/doi.org\/10.15620\/cdc:135850","DOI":"10.15620\/cdc:135850"},{"issue":"2","key":"1235_CR120","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1111\/add.16689","volume":"120","author":"J Tsai","year":"2025","unstructured":"Tsai J, Szymkowiak D, Beydoun HA. Drug overdose deaths among homeless veterans in the United States Department of Veterans Affairs healthcare system. Addiction. 2025;120(2):306\u201315.","journal-title":"Addiction"},{"key":"1235_CR121","unstructured":"Tuazon E ST, Weitz A, Gasdaska B, Clarke-Crichton G, Zaidi I, Fulmer C, McAteer J, and Mantha S. Unintentional Drug Poisoning (Overdose) Deaths in New York City in 2023. New York City Department of Health and Mental Hygiene: Epi Data Brief. 2024. https:\/\/www.nyc.gov\/assets\/doh\/downloads\/pdf\/epi\/databrief142.pdf. Accessed 26 Oct, 2024."},{"key":"1235_CR122","doi-asserted-by":"publisher","DOI":"10.1177\/1357633X2311956","author":"J Tay Wee Teck","year":"2023","unstructured":"Tay Wee Teck J, Butner JL, Baldacchino A. Understanding the use of telemedicine across different opioid use disorder treatment models: a scoping review. J Telemed Telecare. 2023. https:\/\/doi.org\/10.1177\/1357633X2311956.","journal-title":"J Telemed Telecare"},{"issue":"11","key":"1235_CR123","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1001\/jamapsychiatry.2020.1511","volume":"77","author":"PJ Joudrey","year":"2020","unstructured":"Joudrey PJ, Edelman EJ, Wang EA. Methadone for opioid use disorder\u2014decades of effectiveness but still miles away in the US. JAMA Psychiat. 2020;77(11):1105\u20136.","journal-title":"JAMA Psychiat"},{"issue":"Suppl","key":"1235_CR124","doi-asserted-by":"publisher","first-page":"117","DOI":"10.2105\/AJPH.2021.306665","volume":"112","author":"C Simon","year":"2022","unstructured":"Simon C, Vincent L, Coulter A, Salazar Z, Voyles N, Roberts L, et al. The methadone manifesto: treatment experiences and policy recommendations from methadone patient activists. Am Public Health Assoc. 2022;112(Suppl):117\u201322.","journal-title":"Am Public Health Assoc"},{"key":"1235_CR125","unstructured":"Federal Guidelines for Opioid Treatment Programs. Substance Abuse and Mental Health Services Administration, Department of Health and Human Services. 2015. https:\/\/library.samhsa.gov\/product\/federal-guidelines-opioid-treatment-programs-2015\/pep15-fedguideotp. Accessed 9 Apr 2025."},{"key":"1235_CR126","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2021.108449","author":"S Brothers","year":"2021","unstructured":"Brothers S, Viera A, Heimer R. Changes in methadone program practices and fatal methadone overdose rates in Connecticut during COVID-19. J Subst Abuse Treat. 2021. https:\/\/doi.org\/10.1016\/j.jsat.2021.108449.","journal-title":"J Subst Abuse Treat"},{"issue":"9","key":"1235_CR127","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1001\/jamapsychiatry.2022.1776","volume":"79","author":"CM Jones","year":"2022","unstructured":"Jones CM, Compton WM, Han B, Baldwin G, Volkow ND. Methadone-involved overdose deaths in the US before and after federal policy changes expanding take-home methadone doses from opioid treatment programs. JAMA Psychiat. 2022;79(9):932\u20134.","journal-title":"JAMA Psychiat"},{"key":"1235_CR128","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-024-00935-w","author":"G Kolla","year":"2024","unstructured":"Kolla G, Tarannum CN, Fajber K, Worku F, Norris K, Long C, et al. Substance use care innovations during COVID-19: barriers and facilitators to the provision of safer supply at a toronto COVID-19 isolation and recovery site. Harm Reduction J. 2024. https:\/\/doi.org\/10.1186\/s12954-024-00935-w.","journal-title":"Harm Reduction J"},{"key":"1235_CR129","doi-asserted-by":"publisher","DOI":"10.1080\/09687637.2024.2356746","author":"R Rigoni","year":"2024","unstructured":"Rigoni R, Tammi T. Closing doors, opening windows\u2013adaptations and opportunities for harm reduction services during the COVID-19 pandemic in Europe. Drugs Educ Prevent Policy. 2024. https:\/\/doi.org\/10.1080\/09687637.2024.2356746.","journal-title":"Drugs Educ Prevent Policy"},{"key":"1235_CR130","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.q615","author":"A Slaunwhite","year":"2024","unstructured":"Slaunwhite A, Min JE, Palis H, Urbanoski K, Pauly B, Barker B, Crabtree A, Bach P, Krebs E, Dale L, Meilleur L. Effect of Risk Mitigation Guidance for opioid and stimulant dispensations on mortality and acute care visits during dual public health emergencies: retrospective cohort study. BMJ. 2024. https:\/\/doi.org\/10.1136\/bmj.q615.","journal-title":"BMJ"},{"key":"1235_CR131","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1007\/s11606-020-06257-4","volume":"35","author":"K Mackey","year":"2020","unstructured":"Mackey K, Veazie S, Anderson J, Bourne D, Peterson K. Barriers and facilitators to the use of medications for opioid use disorder: a rapid review. J Gen Intern Med. 2020;35:954\u201363.","journal-title":"J Gen Intern Med"},{"key":"1235_CR132","unstructured":"Medications for the Treatment of Opioid Use Disorder. Substance Abuse and Mental Health Services Administration, Department of Health and Human Services. 2024. https:\/\/www.federalregister.gov\/documents\/2024\/02\/02\/2024-01693\/medications-for-the-treatment-of-opioid-use-disorder. Accessed 9 Apr 2025."},{"key":"1235_CR133","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-4272282\/v1","author":"M Davoust","year":"2024","unstructured":"Davoust M, Bazzi AR, Blakemore S, Blodgett J, Cheng A, Fielman S, et al. Patient and clinician experiences with the implementation of telemedicine and related adaptations in office-based buprenorphine treatment during the COVID-19 pandemic: a qualitative study. Research Square. 2024. https:\/\/doi.org\/10.21203\/rs.3.rs-4272282\/v1.","journal-title":"Research Square"},{"key":"1235_CR134","doi-asserted-by":"publisher","DOI":"10.1016\/j.josat.2024.209429","author":"M Lowenstein","year":"2024","unstructured":"Lowenstein M, Popova E, Jalloh A, Mazzella S, Botcheos D, Bertocchi J, et al. The mobile overdose response program: a mobile, low-threshold opioid use disorder treatment model in philadelphia. J Subst Use Addict Treat. 2024. https:\/\/doi.org\/10.1016\/j.josat.2024.209429.","journal-title":"J Subst Use Addict Treat"}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-025-01235-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12954-025-01235-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-025-01235-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T06:00:02Z","timestamp":1757311202000},"score":1,"resource":{"primary":{"URL":"https:\/\/harmreductionjournal.biomedcentral.com\/articles\/10.1186\/s12954-025-01235-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,29]]},"references-count":134,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1235"],"URL":"https:\/\/doi.org\/10.1186\/s12954-025-01235-7","relation":{},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,29]]},"assertion":[{"value":"4 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"132"}}